Loading provider…
Loading provider…
Gastroenterology Physician in Pittsburgh, PA
NPI: 1548211998Primary Practice Location
UPMC PRESBYTERIAN SHADYSIDE
3459 5th Ave, Pittsburgh, PA
Primary Employer
Bioscrip Infusion Services
optioncarehealth.com
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
PA State Medical License
2008 - 2026
WI State Medical License
1997 - 2009
OH State Medical License
1993 - 1998
Jacobs School of Medicine and Biomedical Sciences
medicine.buffalo.edu
Medical School
Until 1988
Case Western Reserve University/University Hospitals Cleveland Medical Center
Fellowship • Gastroenterology
1991 - 1993
Rhode Island Hospital/Brown University Health
Residency • Internal Medicine
1988 - 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 92 | 164 |
| 2 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 15 | 15 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 13 | 13 |
Authors: Heidemann, Jan, Ogawa, Hitoshi, Rafiee, Parvaneh, Lügering, Norbert, Maaser, Christian, Domschke, Wolfram, Binion, David G, Dwinell, Michael B
Journal: Am J Physiol Gastrointest Liver Physiol
Publication Date: 2004-02-05
Authors: Heidemann, Jan, Ogawa, Hitoshi, Otterson, Mary F, Shidham, Vinod B, Binion, David G
Journal: Dis Colon Rectum
Publication Date: 2004-01-14
Narcotic use in patients with Crohn's disease.
Authors: Raymond Cross
Journal: Am J Gastroenterol
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: TAK-018, DRUG: TAK-018 Placebo
Lead Sponsor: Shire
Collaborators: Takeda Development Center Americas, Inc.
Lead Sponsor: Paul Szabolcs
Intervention / Treatment: DRUG: Rituximab, DRUG: Cyclophosphamide, DRUG: Melphalan, DRUG: Mesna, DRUG: G-CSF, DRUG: Thiotepa, DRUG: Alemtuzumab, DRUG: ATG, BIOLOGICAL: autologous CD34-selected peripheral blood stem cells transplant